24/7
Buzz
Startups
VC
AI
Innovation
Opinions
Events
Promising Startups 2024
BiblioTech
Boarding Pass
Corporate
Appointments
CTalk
Tech Gateways
2025 VC survey
@Finance
Ctech Testimonials
Shopping
Projects
Spotlight
About
Newsletter
Contact us
Facebook
Twitter
ACCESSIBILITY
by
Homepage
Glaucoma
Tags search
HOME
24/7
buzz
STARTUPS
VC
AI
Innovation
OPINIONS
EVENTS
SHOPPING
ABOUT
teram of use
Privacy Policy
NEWSLETTER
SEARCH
CONTACT US
ACCESSIBILITY
24/7
Headlines
20:22
Nvidia secures 29,000 sqm in Yokneam as Israeli build-out accelerates
14:10
Tower Semiconductor surges after Nvidia deal promises to double AI data center speeds
13:17
Varonis acquires AllTrue.ai for $150 million to oversee enterprise AI
12:41
“SaaSmargeddon” is here: AI threatens the core of Software-as-a-Service
More stories
Buzz
Most popular
Daily
Weekly
1
Israeli startup raises $6.2 million to turn social media video into intelligence
2
Cyera employees to sell tens of millions in shares at $9 billion valuation
3
Israeli defense firms target Asia as Singapore Airshow opens amid regional arms race
4
Remitly cuts 110 jobs in Israel and closes R&D hub three years after $80 million Rewire acquisition
5
Tomorrow.io raises $175 million at over $1 billion valuation to build AI-driven weather satellite network
More news
Glaucoma
4 stories about Glaucoma
The 83-year-old who sold his invention for $466 million, and still walks to work every morning
14.08.25
|
Roni Dori
Michael Belkin’s journey from rooftop experiments to global glaucoma breakthroughs proves some minds never retire.
The Israeli startup treating the silent thief of sight
30.01.22
|
Yafit Ovadia
BELKIN Vision is using an automated laser procedure to tackle glaucoma, a disease that can lead to irreversible blindness
Belkin Laser announces $12.2 million raised in series B funding
21.07.20
|
Hagar Ravet
The company is in the midst of clinical testing of its one-second glaucoma treatment with the product expected to enter the market in two years
Shenzhen-listed Pharma Company to Acquire Tel Aviv-based Medtech Company IOPtima
21.11.17
|
Lilach Baumer
The Chengdu Kanghong Pharma Group will buy Tel Aviv-based IOPtima in four stages, the latter announced Tuesday through its parent company listed on the Tel Aviv Stock Exchange